Antiplatelet effects of antidepressant treatment: A randomized comparison between escitalopram and nortriptyline

Thrombosis Research

Volumn 126, Issue 2, 2010, Pages

  Flöck, Anne ^a   Zobel, Astrid ^a   Bauriedel, Gerhard ^a   Tuleta, Izabela ^a   Hammerstingl, Christoph ^a   Höfels, Susanne ^a   Schuhmacher, Anna ^a   Maier, Wolfgang ^a   Nickenig, Georg ^a   Skowasch, Dirk ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Escitalopram; Major depression; Nortriptyline; Platelet aggregation

Indexed keywords

ADENOSINE DIPHOSPHATE; COLLAGEN; ESCITALOPRAM; NORTRIPTYLINE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; RANDOMIZATION; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE FUNCTION; TREATMENT RESPONSE;

ADULT; ANTIDEPRESSIVE AGENTS; BLOOD PLATELETS; CITALOPRAM; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NORTRIPTYLINE; PLATELET AGGREGATION;

EID: 77955712346     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.04.020     Document Type: Article

References (30)

1. C.M. O'Connor, P.A. Gurbel, and V.L. Serebruany Depression and ischemic heart disease Am Heart J 140 2000 63 69
2. P. Rickenbacher, and M. Pfisterer Time has come to have a closer look at the management of cardiovascular disease in elderly Eur Heart J 23 2002 993 995
3. L.L. Judd, P.J. Schettler, and H.S. Akiskal The prevalence, clinical relevance, and public health significance of subthreshold depressions Psychiatr Clin North Am 25 2002 685 698
4. W. Jiang, R.R. Krishnan, and C.M. O'Connor Depression and heart disease: evidence of a link, and its therapeutic implications CNS Drugs 16 2002 111 127
5. C.M. O'Connor, W. Jiang, M. Kuchibhatla, R.H. Mehta, G.L. Clary, and M.S. Cuffe Antidepressant use, depression, and survival in patients with heart failure Arch Intern Med 168 2008 2232 2237
6. S.P. Roose Depression, anxiety, and the cardiovascular system: the psychiatrist's perspective J Clin Psychiatry 62 Suppl 8 2001 19 22
7. J.C. Barefoot, and M. Schroll Symptoms of depression, acute myocardial infarction, and total mortality in a Community sample Circulation 93 1996 1976 1980
8. N. Frasure-Smith, F. Lesperance, M. Juneau, M. Talajic, and M.G. Bourassa Gender, depression, and one-year prognosis after myocardial infarction Psychosom Med 61 1999 26 37
9. R. von Känel Platelet hyperactivity in clinical depression and the beneficial effect of antidepressive drug treatment: how strong is the evidence? Acta Psychiatr Scand 110 2004 163 177
10. W. Linden, C. Stossel, and J. Maurice Psychosocial interventions for patients with coronary artery disease: a meta-analysis Arch Intern Med 156 1996 745 752
11. A.H. Glassman, C.M. ÓConnor, R.M. Califf, K. Swedberg, P. Schwartz, and J.T. Bigger Jr Sertraline treatment of major depression in patients with acute MI or unstable angina JAMA 288 2002 701 709
12. R. Uher, W. Maier, J. Hauser, A. Marusic, C. Schmael, and O. Mors Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression Br J Psychiatry 194 2009 252 259
13. R. Uher, O. Mors, J. Hauser, M. Rietschel, W. Maier, and D. Kozel Body weight as a predictor of antidepressant efficacy in the GENDEP project J Affect Disord 118 2009 147 154
14. G. Bauriedel, D. Skowasch, M. Schneider, R. Andrié, A. Jabs, and B. Lüderitz Antiplatelet effects of angiotensin-converting enzyme inhibitors compared with aspirin and clopidogrel: a pilot study with whole-blood aggregometry Am Heart J 145 2003 343 348
15. I. Tuleta, G. Bauriedel, I. Hasenbank, R. Andrié, S. Pabst, and G. Nickenig Antiplatelet effects of n-3 polyunsaturated fatty acids compared with aspirin: A pilot study with whole-blood aggregometry Thromb Res 124 2009 724 726
16. M.W. Agelink, C. Boz, H. Ullrich, and J. Andrich Relationship between major depression and heart rate variability. Clinical consequences and implications for antidepressive treatment Psychiatry Res 113 2002 139 149
17. B. Haenisch, K. Linsel, M. Brüss, R. Gilsbach, P. Propping, and M.M. Nöthen Association of major depression with rare functional variants in norepinephrine transporter and serotonin (1A) receptor genes Am J Genet B Neuropsychiatr Genet 105 2009 1013 1016
18. B.E. Leonard The HPA and immune axes in stress: the involvement of the serotonergic system Eur Psychiatry 20 2005 302 306
19. R. Leo, G. Di Lorenzo, M. Tesauro, C. Razzini, G.B. Forleo, and G. Chiricolo Association between enhanced soluble CD40 ligand proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy J Clin Psychiatry 67 2006 1760 1766
20. M.A. Whooley, P. de Jonge, E. Vittinghoff, C. Otte, R. Moos, and R.M. Carney Depressive symptoms, health behaviours, and risk of cardiovascular events in patients with coronary heart disease JAMA 300 2008 2379 2388
21. R.C. Ziegelstein, J.A. Fauerbach, S.S. Stevens, J. Romanelli, D.P. Richter, and D.E. Bush Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction Arch Intern Med 160 2000 1818 1823
22. V. Pignay-Demaria, F. Lesperance, R.G. Demaria, N. Frasure-Smith, and L.P. Perrault Depression and anxiety and outcomes of coronary artery bypass surgery Ann Thorac Surg 75 2003 314 321
23. S.P. Roose, and M. Miyazaki Pharmacologic treatment of depression in patients with heart disease Psychosom Med 67 Suppl 1 2005 54 57
24. T.C. Somberg, and R.R. Arora Depression and heart disease: therapeutic implications Cardiology 111 2008 75 81
25. R.C. Ziegelstein, K. Parakh, A. Sakhuja, and U. Bhat Platelet function in patients with major depression Int Med J 39 2009 38 43
26. J.H. Markovitz, J.L. Shuster, W.S. Chitwood, R.S. May, and L.C. Tolbert Platelet activation in depression and effects of sertraline treatment: an open label study Am J Psychiatry 157 2000 1006 1008
27. D.J. Mc Closkey, T.T. Postolache, B.J. Vittone, R.A. Wesley, and M.E. Rick Selective Serotonin Reuptake Inhibitors (SSRIs): Measurement of effect on platelet function Transl Res 151 2008 168 172
28. V.L. Serebruany, A.H. Glassman, A.I. Malinin, C.B. Nemeroff, D.L. Musselman, and L.T. van Zyl Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: The Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy Circulation 108 2003 939 944
29. W.H. Chen, X. Cheng, P.Y. Lee, W. Ng, J.Y. Kwok, and F.H. Tse Aspirin resistance and adverse clinical events in patients with coronary artery disease Am J Med 167 2007 1593 1599
30. J.L. Mega, S.L. Close, S.D. Wiviott, L. Shen, R.D. Hockett, and J.T. Brandt Cytochrome P-450 polymorphisms and response to clopidogrel N Engl J 360 2009 354 362